Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RH | Common Stock | Options Exercise | $76.2K | +3K | +26.31% | $25.39* | 14.4K | Mar 31, 2022 | Direct | |
transaction | RH | Common Stock | Options Exercise | $890K | +20K | +138.88% | $44.52* | 34.4K | Mar 31, 2022 | Direct | |
transaction | RH | Common Stock | Sale | -$527K | -1.63K | -4.73% | $324.12 | 32.8K | Mar 31, 2022 | Direct | F1, F7 |
transaction | RH | Common Stock | Sale | -$972K | -2.99K | -9.12% | $325.24 | 29.8K | Mar 31, 2022 | Direct | F2, F7 |
transaction | RH | Common Stock | Sale | -$4.29M | -13.2K | -44.18% | $326.14 | 16.6K | Mar 31, 2022 | Direct | F3, F7 |
transaction | RH | Common Stock | Sale | -$3.04M | -9.31K | -56.02% | $326.86 | 7.31K | Mar 31, 2022 | Direct | F4, F7 |
transaction | RH | Common Stock | Sale | -$193K | -590 | -8.07% | $327.79 | 6.72K | Mar 31, 2022 | Direct | F5, F7 |
transaction | RH | Common Stock | Sale | -$362K | -1.1K | -16.36% | $329.02 | 5.62K | Mar 31, 2022 | Direct | F6, F7 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RH | Employee Stock Option (right to buy) | Options Exercise | $0 | -3K | -100% | $0.00* | 0 | Mar 31, 2022 | Common Stock | 3K | $25.39 | Direct | F8 |
transaction | RH | Employee Stock Option (right to buy) | Options Exercise | $0 | -20K | -100% | $0.00* | 0 | Mar 31, 2022 | Common Stock | 20K | $44.52 | Direct | F9 |
Id | Content |
---|---|
F1 | This transaction was executed in multiple trades ranging from $323.61 to $324.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
F2 | This transaction was executed in multiple trades ranging from $324.61 to $325.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
F3 | This transaction was executed in multiple trades ranging from $325.61 to $326.6. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
F4 | This transaction was executed in multiple trades ranging from $326.61 to $327.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
F5 | This transaction was executed in multiple trades ranging from $327.68 to $328.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
F6 | This transaction was executed in multiple trades ranging from $328.81 to $329.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
F7 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
F8 | Option vested in five equal annual installments beginning on 6/27/2017 and ending on 6/27/2021. |
F9 | Option vested in five equal annual installments beginning on 4/21/2017 and ending on 4/21/2021. |